hydrazine has been researched along with Lung Neoplasms in 148 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 89 (60.14) | 18.7374 |
| 1990's | 11 (7.43) | 18.2507 |
| 2000's | 9 (6.08) | 29.6817 |
| 2010's | 26 (17.57) | 24.3611 |
| 2020's | 13 (8.78) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, BW; Colen, R; Fu, S; Gong, J; Hong, DS; Janku, F; Karp, DD; McQuinn, L; Meric-Bernstam, F; Milton, DR; Naing, A; Piha-Paul, SA; Shah, J; Stephen, BA; Sulovic, S; Thein, KZ; Tsimberidou, A; Yap, TA | 1 |
| Anh, DT; Dung, DTM; Dung, PTP; Hai, PT; Han, SB; Huy, LD; Jun, HW; Kang, JS; Kwon, JH; Nam, NH; Park, EJ; Tung, TT; Young Ji, A | 1 |
| Higuchi, J; Honda, N; Komura, N; Nakanishi, Y | 1 |
| Chen, Z; Fan, J; Guo, C; Qi, X; Wang, J; Wang, L; Wu, X; Yin, C; Zhang, S; Zhu, W | 1 |
| Anh, DT; Dung, DTM; Han, SB; Kang, JS; Kwon, JH; Na, IH; Nam, NH; Park, EJ; Phan, DTP; Tung, TT | 1 |
| Atagi, S; Furuse, J; Higashiguchi, T; Kojima, T; Matano, Y; Minato, K; Mizukami, T; Morishima, E; Muro, K; Naito, T; Takayama, K; Takiguchi, T; Tamura, K; Tanaka, K; Uchino, J | 1 |
| Chung, JH; Mahmudunnabi, RG; Park, DS; Seo, KD; Shiddiky, MJA; Shim, YB; Umer, M | 1 |
| Maruyama, M; Otowa, K; Sakagami, H; Usuda, K | 1 |
| Song, P; Zhang, L | 1 |
| Fukuhara, S; Ito, M; Jo, H; Kanda, S; Maeshima, AM; Ohe, Y; Okuma, Y; Yoshida, T | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Arai, H; Inui, A; Wakabayashi, H | 1 |
| Fonseca, GWPD; von Haehling, S | 1 |
| Bie, Z; Chen, J; Dong, Z; Huang, D; Jiang, R; Jiang, X; Li, L; Li, M; Lin, L; Liu, Z; Meng, Z; Qin, T; Sun, T; Wang, J; Wang, L; Yang, G; Yu, J; Zhang, C; Zhang, M; Zhang, Y | 1 |
| Abernethy, A; Currow, D; Fearon, KC; Friend, J; Milanowski, J; Temel, JS | 1 |
| Borsoi, L; Cairns, J; Meregaglia, M; Tarricone, R | 1 |
| Hanaoka, M; Koizumi, T; Nagata, C; Nishie, K; Yamamoto, S | 1 |
| Aoe, K; Eguchi, K; Katakami, N; Kitajima, H; Komura, N; Kondo, M; Naito, T; Saito, H; Sato, K; Takayama, K; Takiguchi, T; Takiguchi, Y; Tsuji, T; Uchino, J; Yamada, K; Yokoyama, T; Yoshimori, K | 1 |
| Crawford, J | 1 |
| Sidaway, P | 1 |
| Qi, Y; Qiao, Q; Qin, X; Song, Q; Wu, T; Yang, C; Zhang, Z | 1 |
| Arnold, MA; Bid, HK; Brandolini, L; Cam, H; Cam, M; Gross, AC; Hinckley, JM; Houghton, PJ; London, CA; Mo, X; Phelps, DA; Roberts, RD; Saraf, AJ; Winget, SA | 1 |
| Cheng, D; Li, B; Lin, QY; Meng, L; Shi, H; Tan, H; Zhang, Y | 1 |
| Albayrak, G; Dogan Turacli, I; Korkmaz, FD; Tozcu, D | 1 |
| Chen, Z; Li, Z; Wang, X; Xia, W; Yang, X; Zeng, Q | 1 |
| Liu, JW; Xiong, ZQ; Yang, C; Zhao, M; Zhu, ZC | 1 |
| Baker, DL; Bittman, R; Fells, JI; Fujiwara, Y; Kirby, RJ; Lee, SC; Lim, KG; Liu, J; Miller, DD; Nelson, S; Norman, DD; Papoian, R; Parrill, AL; Patil, R; Seibel, W; Tigyi, G; Tsukahara, R | 1 |
| Chen, GG; Guo, HZ; Huang, RY; Huang, Y; Li, MY; Li, SS; Zeng, X; Zhang, X | 1 |
| Chien, W; Ding, L; E-Ling, GL; Hattori, N; Kauffman, M; Koeffler, HP; Lim, SL; Nakamaki, T; Shacham, S; Sudo, M; Sun, H; Sun, Q | 1 |
| Beaumont, JL; Cella, D; Friend, J; Salsman, JM; Wortman, K; Yan, Y | 1 |
| Bhattacharyya, N; Das, AK; Goswami, S; Khanra, K; Maity, S; Saha, U | 1 |
| Garcia, JM; Zhang, H | 1 |
| Cominetti, D; De Cesare, M; Deraco, M; Doldi, V; Friedlander, S; Gandellini, P; Kauffman, MG; Landesman, Y; Lopergolo, A; Pennati, M; Shacham, S; Zaffaroni, N | 1 |
| Morris, JK; Springett, AL; Wald, NJ | 1 |
| Aoe, K; Atagi, S; Eguchi, K; Kagamu, H; Katakami, N; Komura, N; Koyama, A; Saito, H; Takayama, K; Takiguchi, Y; Yokoyama, T; Yoshimori, K | 1 |
| Biancifiori, C | 6 |
| Dong, WL; Miao, JY; Wu, LL; Zhao, BX; Zheng, LW | 1 |
| Djaballah, H; Shum, D; Somwar, R; Varmus, H | 1 |
| Chen, GG; Hsin, MK; Huang, RY; Li, MY; Ma, LT; Mok, TS; Underwood, MJ; Warner, TD | 1 |
| Nagel, D; Toth, B | 4 |
| Foote, MB; Huang, L; Kim, SK | 1 |
| Cai, HD; Dong, F; Fu, D; Hou, M; Li, D; Lü, ML; Lü, ZW; Wang, J; Yu, F; Yuan, XY; Zhang, XP | 1 |
| Erickson-Miller, CL; Figueroa, DJ; Kamel, YM; Kirchner, J; Liu, Y; Martin, AM; Messam, C; Ottesen, L; Pillarisetti, K | 1 |
| BIANCIFIORI, C; RIBACCHI, R | 1 |
| BIANCIFIORI, C; BUCCIARELLI, E; CLAYSON, DB; SANTILLI, FE | 1 |
| Baroni, D; Brambilla, G; Novello, L; Robbiano, L | 1 |
| Gehrmann, M | 1 |
| Decristoforo, C; Faintuch-Linkowski, B; Haubner, R; Hernandez-Gonzales, I; Rey, A; Rodrigo, T; Rupprich, M; von Guggenberg, E | 1 |
| Fröss-Baron, K; Gołkowski, F; Hubalewska-Dydejczyk, A; Huszno, B; Mikołajczak, R; Sowa-Staszczak, A | 1 |
| Dong, ZW; Ge, X; Meng, N; Miao, JY; Shin, DS; Xia, Y; Zhao, BX | 1 |
| Austin, JH; Barr, RG; Hamade, NK; Mesia-Vela, S; Powell, CA; Santella, RM; Wang, Y; Yeh, CC | 1 |
| Grant, GA; Millican, DM; Roe, FJ | 1 |
| Bhalerao, EB; Bhide, SV; Maru, GB; Sarode, AV | 1 |
| Bonsall, J; Boreham, J; Doll, R; Wald, N | 1 |
| Danova, LA; Filov, VA; Gershanovich, ML; Ivin, BA | 1 |
| Bhide, SV; Maru, GB | 1 |
| Bennicelli, C; Brambilla, G; Cavanna, M; De Flora, S; Parodi, S; Pino, A; Robbiano, L | 1 |
| Nagel, D; Patil, K; Toth, B | 3 |
| Nagel, D; Raha, C; Toth, B | 1 |
| Patil, K; Toth, B | 1 |
| Toth, B | 7 |
| Green, MR; Herndon, JE; Kosty, MP; McIntyre, OR | 1 |
| Coughlin, K; Fleishman, SB; Green, MR; Herndon, JE; Kornblith, AB; Kosty, MP; Morris, JC; Mortimer, J; Scalzo, A | 1 |
| Ghosh, C; Goldberg, RM; Jett, JR; Kugler, JW; Kuross, SA; Loprinzi, CL; Mailliard, JA; Maksymiuk, AW; Pfeifle, DM; Su, JQ | 1 |
| Divo, AA; Loomis, RH; Penketh, PG; Rose, WC; Sartorelli, AC; Shyam, K | 1 |
| Cera, PJ; Cha, SS; Creagan, ET; Goldberg, RM; Jung, SH; Marschke, RF; Myers, JL; Schleusener, JT; Tazelaar, HD | 1 |
| Fleishman, S; Green, MR; Herndon, JE; Kosty, MP | 1 |
| Barcellos-Hoff, MH; Chesler, L; Chong, H; Cox, GW; DeGraff, W; Kim, SJ; Roberts, AB; Simpson, JT; Vodovotz, Y; Wink, DA | 1 |
| Froines, J; Moncau, J; Morgenstern, H; Ritz, B | 1 |
| Dutta, S; Ghosh, M; Sanyal, U | 1 |
| Chen, Y; Honn, KV; Lamberti, M; Li, L; Nie, D; Szekeres, K; Tang, K; Zacharek, A | 1 |
| Shimizu, H; Toth, B | 1 |
| Erickson, J; Toth, B | 1 |
| Coulston, F; Golberg, L; Iatropoulos, MJ | 1 |
| Anisimov, VN; Dilman, VM | 1 |
| Hoffmann, D; Patil, K; Schmeltz, I; Toth, B; Wallcave, L | 1 |
| Bhide, SV | 1 |
| Malick, L; Shimizu, H; Toth, B | 1 |
| Bhide, SV; D'Souza, RA; Ranadive, KJ; Sawai, MM | 1 |
| Bhide, SV; D'souza, RA; Maru, GB | 1 |
| Erickson, J; Kupper, R; Nagel, D; Toth, B | 2 |
| Nagel, D; Shimizu, H; Toth, B | 3 |
| Ali, I; Block, JB; Bulcavage, L; Chlebowski, JS; Chlebowski, RT; Elashoff, R; Grosvenor, M; Oktay, E | 1 |
| Gold, J | 1 |
| Chlebowski, RT; Heber, D; Tayek, JA | 1 |
| Bridgman, NM | 1 |
| Bufalari, A; Cavaliere, A; Vitali, R | 1 |
| Shubik, P | 1 |
| Ribacchi, R | 2 |
| Baló, J; Juhász, J; Szende, B | 1 |
| Lesobre, R; Ruffino, J; Tubiana, M | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E | 1 |
| Benjamin, T; Ward, JM; Weisburger, JH; Yamamoto, RS | 1 |
| Kokron, O; Letnansky, K; Titscher, R | 1 |
| Pergola, M; Perrone, V; Zarrilli, D | 1 |
| Grobmyer, AJ; Ricci, JA; Wilson, KS | 1 |
| Derriks, R; Heynen, E; Mannes, P; Moens, R | 1 |
| Jover, A; Levy, A; Migueres, J | 1 |
| Bucciarelli, E | 1 |
| Toth, B; Wilson, RB | 1 |
| Connors, TA | 1 |
| Weisburger, JH; Yamamoto, RS | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E; Price, JM | 1 |
| Cremlyn, RJ; Roe, FJ | 1 |
| Hammer, B | 1 |
| Botkin, C; Kelly, MG; O'Gara, RW; Yancey, ST | 1 |
| Battesti, JP | 1 |
| Akoun, G; Brocard, H | 1 |
| Genevrier, R; Gouletquer, J | 1 |
| Foubert, C; Lemenager, J; Neel, JP | 1 |
| Lewest, G; Reboul, AR | 1 |
| Chauvet, MC; Lenail, C; Maisse, P; Morere, P; Stain, JP; Vaudour, P | 1 |
| Biancifiori, C; Severi, L | 1 |
| Bernard, E; Israel, L | 1 |
| Biancifiori, C; Bucciarelli, E; Rosi, F | 1 |
| Giraldo, G; Ribacchi, R | 1 |
| Botkin, C; Gadekar, K; Kelly, MG; O'Gara, RW; Oliverio, VT; Yancey, ST | 1 |
| Berenblum, I; Chen, L; Haran-Ghera, N; Mirvish, SS | 1 |
| Kohout, J | 1 |
| Milia, U | 1 |
| Di Leo, FP; Milia, U | 1 |
| Biancifiori, C; Giornelli Santilli, FE; Milia, U | 1 |
| Biancifiori, C; Giornelli-Santilli, FE; Milia, U; Severi, L | 1 |
6 review(s) available for hydrazine and Lung Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia.
Topics: Anorexia; Cachexia; Carcinoma, Non-Small-Cell Lung; Humans; Hydrazines; Lung Neoplasms; Neoplasms; Oligopeptides | 2021 |
Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
Topics: Age Factors; Body Weight; Cachexia; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Humans; Hydrazines; Lung Neoplasms; Odds Ratio; Oligopeptides; Quality of Life; Randomized Controlled Trials as Topic; Sex Factors; Treatment Outcome | 2017 |
Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Topics: Animals; Anorexia; Appetite; Cachexia; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Humans; Hydrazines; Lung Neoplasms; Oligopeptides; Randomized Controlled Trials as Topic; Receptors, Ghrelin | 2015 |
More about isonicotinic acid hydrazide toxicity.
Topics: Adenocarcinoma; Adenofibroma; Adenoma; Animals; Carcinoma; Chemical and Drug Induced Liver Injury; Cricetinae; Female; Humans; Hydrazines; Isoniazid; Liver Diseases; Liver Neoplasms; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Phenylbutazone; Rats; Sarcoma; Urethane | 1970 |
Hydrazine toxicology--another episode.
Topics: Animals; Carcinogens; Diuresis; Dogs; Drug Synergism; Environmental Exposure; Haplorhini; Humans; Hydrazines; Intestinal Neoplasms; Kidney Diseases; Lung Neoplasms; Lymph Nodes; Methemoglobinemia; Nitrosamines; Phenylhydrazines; Rabbits; Rats; Splenomegaly; Water-Electrolyte Balance | 1969 |
20 trial(s) available for hydrazine and Lung Neoplasms
| Article | Year |
|---|---|
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Hydrazines; Lung Neoplasms; Nausea; Neoplasms; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Triazoles; Vomiting | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
Topics: Aged; Cachexia; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Female; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Placebos; Receptors, Ghrelin | 2017 |
Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Cachexia; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Female; Health Status Indicators; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Netherlands; Oligopeptides; Quality of Life; Regression Analysis; Surveys and Questionnaires; United Kingdom | 2019 |
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
Topics: Aged; Body Composition; Cachexia; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Female; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Oligopeptides | 2018 |
Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Appetite; Appetite Stimulants; Cachexia; Carcinoma, Non-Small-Cell Lung; Fatigue; Female; Hand Strength; Health Status Indicators; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Placebos; Psychometrics; Quality of Life; Receptors, Ghrelin; Reproducibility of Results; Surveys and Questionnaires; Weight Loss | 2015 |
Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
Topics: Aged; Cachexia; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Female; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Oligopeptides; Prognosis; Quality of Life | 2016 |
Isoniazid--an attempt at retrospective prediction. A report of an ad hoc expert groups of the International Commission for Protection Against Environmental Mutagens and Carcinogens.
Topics: Acetyltransferases; Biotransformation; Carcinogens; Chromosomes; Clinical Trials as Topic; Drug Evaluation, Preclinical; Hydrazines; Inactivation, Metabolic; Isoniazid; Liver; Lung Neoplasms; Mutagens; Neoplasms; Risk; Teratogens; Tuberculosis, Pulmonary | 1980 |
Results of clinical study antitumor action of hydrazine sulfate.
Topics: Abdominal Neoplasms; Aged; Clinical Trials as Topic; Female; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neuroblastoma; Sarcoma | 1981 |
Placebo-controlled randomized study of hydrazine sulfate in lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Humans; Hydrazines; Lung Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic | 1995 |
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Female; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Quality of Life; Survival Rate; Vinblastine | 1994 |
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Etoposide; Female; Humans; Hydrazines; Lung Neoplasms; Male; Quality of Life; Survival Rate | 1994 |
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cisplatin; Disease Progression; Etoposide; Female; Humans; Hydrazines; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neuroendocrine Tumors; Prognosis; Staining and Labeling | 1996 |
A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Drug Administration Schedule; Humans; Hydrazines; Longitudinal Studies; Lung Neoplasms; Proportional Hazards Models; Quality of Life; Quality-Adjusted Life Years; Vinblastine | 1997 |
Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drugs, Investigational; Humans; Hydrazines; Lung Neoplasms; Nutrition Assessment; Nutritional Status; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Vinblastine | 1990 |
Hydrazine sulfate in nonsmall-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Hydrazines; Lung Neoplasms; Randomized Controlled Trials as Topic | 1990 |
Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patients.
Topics: Adult; Aged; Cachexia; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydrazines; Lung Neoplasms; Lysine; Male; Middle Aged; Prospective Studies; Proteins; Random Allocation; Serum Albumin; Sex Factors | 1987 |
Malignant hepatoma--controlled therapeutic trials. South African primary liver cancer research group. Initial report.
Topics: Adult; Alkylating Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Gold; Humans; Hydrazines; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mining; Neoplasm Metastasis; South Africa | 1967 |
[Isoniazid and carcinogenesis].
Topics: Adenoma; Adult; Animals; Carbamates; Carcinoma; Child; Clinical Trials as Topic; Female; Humans; Hydrazines; Isoniazid; Lung Neoplasms; Male; Mice; Neoplasms; Neoplasms, Experimental; Pregnancy; Tuberculosis | 1969 |
Treatment of carcinoma of the lung with 1-acetyl-2-picolinoylhydrazine (NSC-68626).
Topics: Aged; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Female; Humans; Hydrazines; Lung Neoplasms; Male; Middle Aged; Paresthesia; Picolines; Sleep Wake Disorders; Vertigo | 1970 |
123 other study(ies) available for hydrazine and Lung Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents.
Topics: Antineoplastic Agents; Benzylidene Compounds; Cell Line, Tumor; Colonic Neoplasms; Fluorouracil; Humans; Hydrazines; Lung Neoplasms; Male; Molecular Docking Simulation; PC-3 Cells; Prostatic Neoplasms; Quinolones; Structure-Activity Relationship | 2022 |
[Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ
Topics: Animals; Cachexia; Carcinoma, Non-Small-Cell Lung; Ghrelin; Humans; Hydrazines; Japan; Lung Neoplasms; Oligopeptides; Rats; Swine; Tablets; Treatment Outcome | 2021 |
EGPI-1, a novel eIF4E/eIF4G interaction inhibitor, inhibits lung cancer cell growth and angiogenesis through Ras/MNK/ERK/eIF4E signaling pathway.
Topics: A549 Cells; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Gene Knockdown Techniques; Humans; Hydrazines; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Signal Transduction; Thiazoles; Up-Regulation; Xenograft Model Antitumor Assays | 2022 |
Design, synthesis and evaluation of novel 2-oxoindoline-based acetohydrazides as antitumor agents.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Enzyme Activators; Humans; Hydrazines; Lung Neoplasms; Male; Prostatic Neoplasms | 2022 |
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
Topics: Anorexia; Body Mass Index; Body Weight; Cachexia; Carcinoma, Non-Small-Cell Lung; Ghrelin; Humans; Hydrazines; Lung Neoplasms; Oligopeptides | 2022 |
Exosomal microRNAs array sensor with a bioconjugate composed of p53 protein and hydrazine for the specific lung cancer detection.
Topics: Biosensing Techniques; DNA; Gold; Humans; Hydrazines; Hydrogen Peroxide; Lung Neoplasms; Metal Nanoparticles; MicroRNAs; Tumor Suppressor Protein p53 | 2022 |
Refractory Monomorphic Ventricular Tachycardia Induced by Anamorelin.
Topics: Carcinoma, Non-Small-Cell Lung; Electrocardiography; Humans; Hydrazines; Lung Neoplasms; Tachycardia, Ventricular | 2023 |
Eltrombopag treatment for severe refractory thrombocytopenia caused by pembrolizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Benzoates; Carcinoma, Non-Small-Cell Lung; Drug Resistance; Humans; Hydrazines; Lung Neoplasms; Male; Pyrazoles; Severity of Illness Index; Thrombocytopenia; Treatment Outcome | 2019 |
Eltrombopag olamine for refractory immune-related thrombocytopenia induced by pembrolizumab in a non-small cell lung cancer patient.
Topics: Antibodies, Monoclonal, Humanized; Benzoates; Carcinoma, Non-Small-Cell Lung; Humans; Hydrazines; Lung Neoplasms; Pyrazoles; Thrombocytopenia | 2020 |
The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
Topics: Cachexia; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Humans; Hydrazines; Japan; Lung Neoplasms; Oligopeptides; Pancreatic Neoplasms | 2021 |
XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a.
Topics: Active Transport, Cell Nucleus; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Cytoplasm; Drug Synergism; Exportin 1 Protein; Female; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Karyopherins; Lung Neoplasms; Mice; Phthalazines; Receptors, Cytoplasmic and Nuclear; Small Cell Lung Carcinoma; Triazoles; Xenograft Model Antitumor Assays | 2021 |
Cancer cachexia: Are we ready to take a step forward?
Topics: Cachexia; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Ghrelin; Humans; Hydrazines; Lung Neoplasms; Neoplasms; Oligopeptides | 2018 |
Palliative care: Anamorelin provides benefit to patients with cachexia.
Topics: Cachexia; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Ghrelin; Humans; Hydrazines; Lung Neoplasms; Oligopeptides; Palliative Care | 2018 |
Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Hydrazines; Indazoles; Lung; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Nanomedicine; Nitric Oxide; Rats; Rats, Sprague-Dawley; Tissue Distribution; Treatment Outcome; Vitamin E; Xenograft Model Antitumor Assays | 2018 |
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.
Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Cytokine Receptor gp130; Drug Evaluation, Preclinical; Follow-Up Studies; Humans; Hydrazines; Interleukin-6; Interleukin-8; Lung; Lung Neoplasms; Male; Mice; Osteosarcoma; Primary Cell Culture; Quinoxalines; Receptors, Interleukin-8A; Sulfonamides; Xenograft Model Antitumor Assays; Young Adult | 2018 |
Preliminary application of micro-SPECT/CT imaging by
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Edetic Acid; Glycine; Humans; Hydrazines; Lung Neoplasms; Male; Mice; Mice, Nude; Nicotinic Acids; Organotechnetium Compounds; Proto-Oncogene Proteins c-met; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2019 |
The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Hydrazines; Lung Neoplasms; Mutation; Oxidative Stress; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras) | 2019 |
Adjudin synergizes with paclitaxel and inhibits cell growth and metastasis by regulating the sirtuin 3-Forkhead box O3a axis in human small-cell lung cancer.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Female; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Indazoles; Lung Neoplasms; Male; Mice; Paclitaxel; Sirtuin 3; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2019 |
XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Down-Regulation; Drug Synergism; Eukaryotic Initiation Factor-4F; Exportin 1 Protein; Humans; Hydrazines; Isoquinolines; Karyopherins; Lung Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred NOD; Mice, SCID; Myeloid Cell Leukemia Sequence 1 Protein; Receptors, Cytoplasmic and Nuclear; RNA, Ribosomal; Triazoles | 2019 |
Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface.
Topics: Animals; Antineoplastic Agents; Benzamides; Benzeneacetamides; Cell Line, Tumor; Drug Screening Assays, Antitumor; High-Throughput Screening Assays; Humans; Hydrazines; Hydrophobic and Hydrophilic Interactions; Indoles; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Mutation; Neoplasm Invasiveness; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship; Sulfonamides; Tetrazoles | 2013 |
Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Benzofurans; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fatty Acids, Unsaturated; Flow Cytometry; Humans; Hydrazines; Immunoenzyme Techniques; Lung Neoplasms; Nitrobenzenes; Real-Time Polymerase Chain Reaction; Receptors, Thromboxane; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfonamides; Sulfonylurea Compounds; Thromboxane A2; Thromboxane-A Synthase | 2014 |
KPT-330 has antitumour activity against non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Exportin 1 Protein; G1 Phase; Genes, p53; Humans; Hydrazines; Karyopherins; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Receptors, Cytoplasmic and Nuclear; Triazoles; Xenograft Model Antitumor Assays | 2014 |
Rapid detection of hydrazine in a naphthol-fused chromenyl loop and its effectiveness in human lung cancer cells: tuning remarkable selectivity via the reaction altered pathway supported by theoretical studies.
Topics: Chromones; Humans; Hydrazines; Lung Neoplasms; Molecular Structure; Naphthols; Quantum Theory; Spectrometry, Fluorescence | 2015 |
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Exportin 1 Protein; G1 Phase Cell Cycle Checkpoints; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Karyopherins; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, SCID; Neoplasm Proteins; Oxadiazoles; Peritoneal Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Survivin; Thiazoles; Triazoles; Tumor Suppressor Protein p53 | 2015 |
Occupational Exposure to Hydrazine and Subsequent Risk of Lung Cancer: 50-Year Follow-Up.
Topics: Adult; Carcinogens; Follow-Up Studies; Humans; Hydrazines; Lung Neoplasms; Male; Occupational Diseases; Occupational Exposure; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Young Adult | 2015 |
Ovarian influence on pulmonary carcinogenesis by hydrazine sulfate in BALB/c/Cb/Se mice.
Topics: Adenoma; Animals; Carcinogens; Carcinoma; Cell Transformation, Neoplastic; Female; Gonadal Steroid Hormones; Hydrazines; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Ovarian Neoplasms; Ovariectomy; Ovary | 1970 |
Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Crystallography, X-Ray; Humans; Hydrazines; Lung Neoplasms; Molecular Conformation; Pyrroles | 2009 |
Identification and preliminary characterization of novel small molecules that inhibit growth of human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA, Neoplasm; Drug Screening Assays, Antitumor; ErbB Receptors; Half-Life; Humans; Hydrazines; Lung Neoplasms; Microsomes, Liver; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Signal Transduction; Small Molecule Libraries | 2009 |
4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinogens; Cell Growth Processes; Cell Survival; Cyclic AMP Response Element-Binding Protein; Extracellular Signal-Regulated MAP Kinases; Fatty Acids, Unsaturated; Humans; Hydrazines; Lung Neoplasms; Nitrosamines; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Thromboxane A2, Prostaglandin H2; Smoking; Thromboxane A2; Thromboxane-A Synthase; Tumor Cells, Cultured | 2011 |
N-ethyl-N-formylhydrazine tumorigenesis in mice.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Drinking Water; Female; Gallbladder Neoplasms; Hemangiosarcoma; Hydrazines; Liver Neoplasms; Lung Neoplasms; Male; Mice; Papilloma; Survival Rate | 1980 |
Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles.
Topics: Animals; Apoptosis; Biomimetic Materials; Calcium Carbonate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytoplasm; Drug Delivery Systems; ErbB Receptors; Female; Fluorescent Dyes; Humans; Hydrazines; Hydrogen-Ion Concentration; Lipids; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Peptides; Random Allocation; Xenograft Model Antitumor Assays | 2013 |
Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Topics: Animals; Cell Line, Tumor; Humans; Hydrazines; Lung Neoplasms; Male; Mice; Mice, Nude; Nicotinic Acids; Receptors, Somatostatin; Technetium | 2012 |
Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.
Topics: Benzoates; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Inhibitory Concentration 50; Lung Neoplasms; Male; Ovarian Neoplasms; Pyrazoles; Receptors, Thrombopoietin | 2012 |
Pulmonary tumours in mice induced by oral isoniazid and its metabolites.
Topics: Animals; Hydrazines; Isoniazid; Lung Neoplasms; Mice; Niacin; Nicotinic Acids | 1962 |
INDUCTION OF HEPATOMAS IN CBA-CB-SE MICE BY HYDRAZINE SULPHATE AND THE LACK OF EFFECT OF CROTON OIL ON TUMOUR INDUCTION IN BALB-C-CB-SE MICE.
Topics: Animals; Carcinoma, Hepatocellular; Croton Oil; Hydrazines; Isoniazid; Isonicotinic Acids; Liver; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Neoplasms; Neoplasms, Experimental; Pathology; Pharmacology; Research; Skin Neoplasms; Sulfates; Toxicology | 1964 |
Correlation between induction of DNA fragmentation in lung cells from rats and humans and carcinogenic activity.
Topics: Adenocarcinoma; Aged; Animals; Cadmium Compounds; Carcinogens; Comet Assay; Dimethylnitrosamine; DNA Breaks, Single-Stranded; DNA Fragmentation; Epithelial Cells; Female; Humans; Hydrazines; Lung; Lung Neoplasms; Male; Methylenebis(chloroaniline); Middle Aged; Nitrites; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Sulfates; Tetranitromethane; Tumor Microenvironment | 2006 |
Drug evaluation: STA-4783--enhancing taxane efficacy by induction of Hsp70.
Topics: Animals; Antineoplastic Agents; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Hydrazines; Lung Neoplasms; Melanoma; RNA, Messenger; Taxoids; Tubulin Modulators | 2006 |
[99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Topics: Animals; Carcinoma, Small Cell; Cell Line, Tumor; Drug Stability; Humans; Hydrazines; Integrin alphaVbeta3; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Nicotinic Acids; Oligopeptides; Organotechnetium Compounds; Peptides, Cyclic; Protein Binding; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2006 |
99mTc-EDDA/HYNIC-octreotate in detection of atypical bronchial carcinoid.
Topics: Adult; Carcinoid Tumor; Edetic Acid; Female; Humans; Hydrazines; Lung Neoplasms; Mediastinal Neoplasms; Neoplasm Metastasis; Nicotinic Acids; Organotechnetium Compounds; Radiography; Radiopharmaceuticals; Somatostatin | 2007 |
Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrazines; Lung Neoplasms; Models, Molecular; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2007 |
No effect of cigarette smoking dose on oxidized plasma proteins.
Topics: Aged; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydrazines; Lung Neoplasms; Male; Mass Screening; Middle Aged; New York City; Oxidative Stress; Protein Carbonylation; Smoking; Surveys and Questionnaires | 2008 |
Carcinogenicity of hydrazine and 1,1-dimethylhydrazine for mouse lung.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Female; Hydrazines; Lung Neoplasms; Mice | 1967 |
Mutagenicity and carcinogenicity of mono- and diacetyl hydrazine.
Topics: Adenocarcinoma, Papillary; Adenoma; Administration, Oral; Animals; Carcinogens; DNA; Female; Hydrazines; Lung Neoplasms; Male; Mice; Microsomes, Liver; Mutagenicity Tests; Mutagens; Salmonella typhimurium; Testis | 1984 |
Occupational exposure to hydrazine and subsequent risk of cancer.
Topics: Chemical Industry; England; Follow-Up Studies; Humans; Hydrazines; Lung Neoplasms; Male; Neoplasms; Occupational Diseases; Risk; Time Factors | 1984 |
1,2-diallylhydrazine dihydrochloride carcinogenesis in mice.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Female; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental | 1982 |
Effect of antioxidants and antitoxicants of isoniazid on the formation of lung tumours in mice by isoniazid and hydrazine sulphate.
Topics: Animals; Antioxidants; Arginine; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Folic Acid; Hydrazines; Isoniazid; Lung Neoplasms; Mice; Neoplasms, Experimental; Pyridoxine; Sodium Glutamate | 1982 |
DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
Topics: Animals; Carcinogens; DNA; Dose-Response Relationship, Drug; Female; Hydrazines; Lethal Dose 50; Liver; Lung; Lung Neoplasms; Male; Mice; Models, Biological; Mutagens; Neoplasms, Experimental; Rats; Salmonella | 1981 |
Carcinogenic effects of 1,1-di-n-butylhydrazine in mice.
Topics: Animals; Carcinogens; Hydrazines; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasms, Experimental; Stomach Neoplasms | 1981 |
1,2-di-n-butylhydrazine dihydrochloride carcinogenesis in mice.
Topics: Adenocarcinoma; Adenoma; Animals; Female; Hydrazines; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Male; Mice | 1981 |
Tumorigenesis with 1,1-diallylhydrazine in mice.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma; Female; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Papilloma; Sex Factors; Stomach Neoplasms | 1981 |
Carcinogenesis by a single dose of N-methyl-N-formylhydrazine.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma, Squamous Cell; Female; Hydrazines; Lung Neoplasms; Male; Mice; Papilloma; Penile Neoplasms | 1980 |
Tumorigenesis by N-n-propyl-N-formylhydrazine in mice.
Topics: Animals; Female; Gallbladder Neoplasms; Hydrazines; Liver Neoplasms; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Penile Neoplasms | 1980 |
Nicotinic acid hydrazide carcinogenesis in mice.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Diet; Drinking; Female; Hydrazines; Lung Neoplasms; Male; Mice; Nicotinic Acids; Sex Factors; Time Factors | 1981 |
Synthesis and evaluation of 1-acyl-1,2-bis(methylsulfonyl)-2-(2- chloroethyl)hydrazines as antineoplastic agents.
Topics: Acylation; Alkylation; Animals; Antineoplastic Agents; Drug Stability; Female; Glutathione; Hydrazines; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Sarcoma, Experimental; Structure-Activity Relationship; Sulfonamides | 1993 |
Regulation of transforming growth factor beta1 by nitric oxide.
Topics: Adenocarcinoma; Animals; Coculture Techniques; Enzyme Induction; Enzyme Precursors; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Image Processing, Computer-Assisted; Interferon-gamma; Lipopolysaccharides; Lung Neoplasms; Macrophage Activation; Macrophages; Mice; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Oxidative Stress; Peptide Fragments; Protein Precursors; Protein Processing, Post-Translational; Proteins; Recombinant Fusion Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 1999 |
Chemical exposures of rocket-engine test-stand personnel and cancer mortality in a cohort of aerospace workers.
Topics: Carcinogens; Cohort Studies; Humans; Hydrazines; Logistic Models; Lung Neoplasms; Male; Neoplasms; Occupational Diseases; Occupational Exposure; Retrospective Studies; Risk Assessment | 1999 |
Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Screening Assays, Antitumor; Humans; Hydrazines; Lung Neoplasms; Male; Mice; Tumor Cells, Cultured | 1999 |
Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Chemotaxis; Dinoprost; Dinoprostone; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Fatty Acids, Unsaturated; Fibroblast Growth Factor 2; Humans; Hydrazines; Lung Neoplasms; Lymphokines; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Rats; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Tumorigenic action of N-n-butyl-N-formylhydrazine in mice.
Topics: Animals; Carcinogens; Clitoris; Female; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Penile Neoplasms; Structure-Activity Relationship; Vulvar Neoplasms | 1980 |
Tumorigenic effects of chronic administration of benzylhydrazine dihydrochloride and phenylhydrazine hydrochloride in Swiss mice.
Topics: Animals; Female; Hydrazines; Lung Neoplasms; Lymphoma; Male; Mice; Neoplasms, Experimental; Neoplasms, Vascular Tissue; Phenylhydrazines; Sex Factors | 1976 |
Lung tumorigenesis by 1,2-diformylhydrazine in mice.
Topics: Adenocarcinoma; Adenoma; Animals; Female; Hydrazines; Lung Neoplasms; Male; Mice | 1978 |
Intestinal carcinogenesis in rats using 1,2-dimethylhydrazine with or without degraded carrageenan.
Topics: Animals; Body Weight; Carrageenan; Cell Nucleolus; Cell Nucleus; Colon; Colonic Neoplasms; Dimethylhydrazines; Duodenal Neoplasms; Duodenum; Female; Hydrazines; Hyperplasia; Ileum; Intestinal Mucosa; Intestinal Neoplasms; Lung Neoplasms; Male; Mitosis; Neoplasms, Glandular and Epithelial; Precancerous Conditions; Rats; Rectal Neoplasms | 1975 |
Potentiation of antitumor effect of cyclophosphamide and hydrazine sulfate by treatment with the antidiabetic agent, 1-phenylethylbiguanide (phenformin).
Topics: Animals; Carcinoma 256, Walker; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Hydrazines; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Phenformin; Sarcoma 180; Uterine Cervical Neoplasms | 1979 |
Induction of tumors in mice with the herbicide succinic acid 2,2-dimethylhydrazide.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinogens; Dimethylhydrazines; Female; Hemangioma; Hemangiosarcoma; Hydrazines; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Methylhydrazines; Mice; Neoplasms, Experimental; Succinates | 1977 |
Formylhydrazine carcinogenesis in mice.
Topics: Adenocarcinoma; Adenoma; Animals; Female; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental | 1978 |
Anticancer properties of isoniazid & hydrazine-sulphate.
Topics: Adenocarcinoma; Animals; Fibrosarcoma; Hydrazines; Isoniazid; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Sarcoma, Experimental | 1978 |
Production of intestinal and other tumors by 1, 2-dimethylhydrazine dihydrochloride in mice. I. A light and transmission electron microscopic study of colonic neoplasms.
Topics: Adenocarcinoma; Adenoma; Animals; Anus Neoplasms; Carcinoma, Squamous Cell; Colon; Dimethylhydrazines; Female; Hemangioma; Hemangiosarcoma; Hydrazines; Intestinal Neoplasms; Intestine, Large; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Mice; Microscopy, Electron; Neoplasms, Experimental | 1976 |
Tumor induction study with allylhydrazine HCl in swiss mice.
Topics: Allyl Compounds; Animals; Female; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Time Factors | 1976 |
Lung tumour incidence in mice treated with hydrazine sulphate.
Topics: Adenocarcinoma; Animals; Carcinogens; Female; Hepatectomy; Hydrazines; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Protein Deficiency; Sex Factors; Species Specificity; Vitamin B Deficiency | 1976 |
Effect of hydrazine sulfate (HS) on nucleic acid biosynthesis and activities of nucleases in swiss mice.
Topics: Animals; Animals, Newborn; Deoxyribonucleases; DNA; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Ribonucleases; RNA | 1976 |
Trimethylhydrazine hydrochloride as a tumor inducer in Swiss mice.
Topics: Adenoma; Animals; Chemical Phenomena; Chemistry; Dimethylhydrazines; Female; Hemangiosarcoma; Hydrazines; Kidney Neoplasms; Lung Neoplasms; Male; Methylhydrazines; Mice; Neoplasms, Experimental; Structure-Activity Relationship | 1976 |
Tumorigenicity of tetramethylhydrazine hydrochloride in Swiss mice.
Topics: Adenoma; Animals; Carcinogens; Female; Hemangioma; Hemangiosarcoma; Hydrazines; Kidney Neoplasms; Lung Neoplasms; Male; Methylation; Methylhydrazines; Mice; Monomethylhydrazine; Neoplasms, Experimental; Structure-Activity Relationship | 1976 |
Tumour induction study with n-amylhydrazine hydrochloride in Swiss mice.
Topics: Adenocarcinoma; Adenoma; Animals; Blood Vessels; Female; Hemangioma; Hemangiosarcoma; Hydrazines; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Mice; Neoplasms, Experimental; Ovarian Neoplasms; Splenic Neoplasms | 1975 |
Tumor induction studies with n-butyl- and n-propylhydrazine hydrochlorides in Swiss mice.
Topics: Adenocarcinoma; Adenoma; Animals; Female; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental | 1975 |
A new life for my cancer patient.
Topics: Appetite; Female; Humans; Hydrazines; Lung Neoplasms; Middle Aged | 1988 |
Carcinogenicity and cocarcinogenicity test of phenobarbital sodium in adult BALB/c mice.
Topics: Animals; Cocarcinogenesis; Female; Hydrazines; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Phenobarbital | 1986 |
Isoniazid: laboratory evidence.
Topics: Adenoma; Animals; Hydrazines; Isoniazid; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Rats | 1985 |
[Demonstration by immunofluorescence of group-specific antigens of the C particles in spontaneous tumors of the lung and those induced by chemicl carcinogens in BALBc mice].
Topics: Animals; Antigens; Cytoplasmic Granules; Epitopes; Fluorescent Antibody Technique; Hydrazines; Inclusion Bodies, Viral; Leukemia, Experimental; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Oncogenic Viruses; Retroviridae; Urethane | 1972 |
[The tumor-inducing action of hydrazine].
Topics: Animals; Carcinogens; Child, Preschool; Female; Humans; Hydrazines; Isoniazid; Leukemia; Liver; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinum; Mice; Neoplasms, Experimental; Spleen | 1967 |
Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Body Weight; Carcinogens; Carcinoma, Squamous Cell; Diet; Female; Formates; Hydrazines; Leukemia, Experimental; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Nitrofurans; Skin Neoplasms; Stomach Neoplasms; Thiazoles; Uterine Neoplasms | 1970 |
[Isolation of C particles from 3 cell lines in vitro from primary tumors of the lung induced with urethane in BALBc mice].
Topics: Adenocarcinoma, Papillary; Animals; Cell Line; Hydrazines; In Vitro Techniques; Inclusion Bodies, Viral; Leukemia, Experimental; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Retroviridae; Urethane | 1972 |
Morphological studies of angiosarcomas induced by 1,2-dimethylhydrazine dihydrochloride in Syrian golden hamsters.
Topics: Alkaline Phosphatase; Animals; Carcinogens; Cell Nucleus; Chromatin; Collagen; Cricetinae; Cytoplasm; Fatty Acids; Female; Heart Neoplasms; Hemangiosarcoma; Histocytochemistry; Hydrazines; Inclusion Bodies; Iron; Liver Neoplasms; Lung Neoplasms; Male; Microscopy, Electron; Neoplasms, Muscle Tissue; Pancreatic Neoplasms; Reticulin | 1972 |
Transplantation of chemically induced metastatic mucinous adenocarcinomas of the jejunum and colon in rats.
Topics: Adenocarcinoma, Mucinous; Animals; Bone Neoplasms; Carcinogens; Colonic Neoplasms; Hydrazines; Intestinal Neoplasms; Jejunum; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Transplantation; Peritoneal Neoplasms; Pleural Neoplasms; Rats; Time Factors; Transplantation, Homologous | 1973 |
[Morphologic modifications in lung neoplasm isografts in the mice induced by hydrazine sulfate].
Topics: Animals; Female; Hydrazines; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Neoplasm Transplantation; Transplantation, Autologous | 1974 |
Local therapy of malignant pleural effusions.
Topics: Animals; Breast Neoplasms; Bronchial Neoplasms; Cattle; Cyclophosphamide; Drug Combinations; Female; Glucose; Gold Isotopes; Humans; Hydrazines; L-Lactate Dehydrogenase; Lactates; Lung Neoplasms; Male; Mannitol; Muramidase; Neoplasm Metastasis; Pancreatic Extracts; Papain; Plant Extracts; Pleural Effusion; Pleural Neoplasms; Podophyllin; Proteins; Radioisotopes; Thymus Extracts; Time Factors | 1974 |
1,1-Dimethylhydrazine (unsymmetrical) carcinogenesis in mice. Light microscopic and ultrastructural studies on neoplastic blood vessels.
Topics: Animals; Blood Vessels; Carcinogens; Female; Hemangiosarcoma; Hydrazines; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Mice; Microscopy, Electron; Neoplasms, Experimental | 1973 |
Ethylhydrazine hydrochloride as a tumor inducer in mice.
Topics: Adenocarcinoma; Adenoma; Administration, Oral; Animals; Female; Hemangioma; Hemangiopericytoma; Hemangiosarcoma; Hydrazines; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Mice; Neoplasms, Experimental; Ovarian Neoplasms; Skin Neoplasms; Splenic Neoplasms; Time Factors; Water | 1974 |
[Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Melanoma; Middle Aged; Nasopharyngeal Neoplasms; Tonsillar Neoplasms | 1966 |
[Cancerogenesis caused by hydrazine sulfate in tracheo-bronchopulmonary isogenic grafts in BALB-c-Cb-Se mice].
Topics: Adenoma; Animals; Animals, Newborn; Bronchi; Carcinoma; Hydrazines; Lung Neoplasms; Lung Transplantation; Mice; Neoplasms, Experimental; Sulfates; Trachea | 1970 |
[Antineoplastic polychemotherapy in thoracic pathology].
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cortisone; Cyclophosphamide; Drug Synergism; Ethinyl Estradiol; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Hydrazines; Hypophysectomy; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Melphalan; Mesothelioma; Methotrexate; Middle Aged; Nandrolone; Neoplasm Metastasis; Ovarian Neoplasms; Podophyllin; Sarcoma; Thiotepa; Vinblastine | 1968 |
[3 years of polychemotherapy of pleuro-pulmonary cancer. Apropos of 95 cases].
Topics: Androgens; Antibiotics, Antineoplastic; Antineoplastic Agents; Ascorbic Acid; Azirines; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Synergism; Fluorouracil; Glucocorticoids; Humans; Hydrazines; Injections, Intramuscular; Injections, Intravenous; Lectins; Lung Neoplasms; Mechlorethamine; Mercaptopurine; Mesothelioma; Methotrexate; Phenylbutazone; Pleural Neoplasms; Thiotepa; Vinblastine | 1968 |
Hydrazine, methylhydrazine and methylhydrazine sulfate carcinogenesis in Swiss mice. Failure of ammonium hydroxide to interfere in the development of tumors.
Topics: Animals; Female; Hodgkin Disease; Hydrazines; Hydroxides; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Quaternary Ammonium Compounds | 1972 |
Benzoylhydrazine carcinogenesis in lungs and lymphoreticular tissues of Swiss mice.
Topics: Animals; Carcinogens; Female; Hodgkin Disease; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental | 1972 |
[Isogenic transplants, in adults and neonatal hosts, of pulmonary tumors induced with hydrazine sulfate in BALB-c-Cb-Se mice: ultrastructural study].
Topics: Age Factors; Animals; Animals, Newborn; Cytoplasmic Granules; Hydrazines; Inclusion Bodies, Viral; Lung Neoplasms; Mice; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Sulfates | 1971 |
[Effect of ovarian hormones in pulmonary cancerogenesis induced with hydrazine sulfate in C3Hb-Cb-Se mide].
Topics: Adenoma; Animals; Carcinoma; Estrogens; Female; Hydrazines; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Sulfates | 1971 |
Blood vessel tumorigenesis by 1,2-dimethylhydrazine dihydrochloride (symmetrical). Gross, light and electron microscopic descriptions. I.
Topics: Animals; Blood Vessels; Fossil Fuels; Hydrazines; Liver; Lung Neoplasms; Mice; Microscopy, Electron; Muscles; Neoplasms, Experimental; Neoplasms, Vascular Tissue; Organ Specificity | 1971 |
An outline of cancer chemotherapy.
Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Asparaginase; Breast Neoplasms; Cells, Cultured; Colonic Neoplasms; Cricetinae; DNA, Neoplasm; Humans; Hydrazines; Hydroxyurea; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Mitomycins; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Rats; Ribonucleotides; Ribosomes; RNA, Neoplasm; Transplantation, Heterologous | 1971 |
Pulmonary and mammary tumors due to hydrazine sulfate in BALB-c-CbSe forced breeder and pseudopregnant mice.
Topics: Adenoma; Animals; Breeding; Carcinoma; Female; Hydrazines; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Pregnancy; Pregnancy, Animal; Pseudopregnancy | 1971 |
Failure of arginine glutamate to inhibit lung tumor formation by isoniazid and hydrazine in mice.
Topics: Animals; Arginine; Glutamates; Hydrazines; Isoniazid; Liver; Lung; Lung Neoplasms; Male; Mice; Neoplasms, Experimental | 1970 |
[Pulmonary and hepatic tumors caused by hydrazine sulfate in reduced doses in BALB-c-Cb-Se mice].
Topics: Adenoma; Animals; Carcinoma; Hydrazines; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasms, Experimental; Sulfates | 1970 |
Comparative carcinogenicity in the rat of 2-hydrazinothiazoles with nitrofuryl, nitrophenyl, or aminophenyl substituents in the 4-position.
Topics: Adenocarcinoma; Adenofibroma; Animals; Body Weight; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Hydrazines; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Rats; Salivary Gland Neoplasms; Splenic Neoplasms; Thiazoles | 1970 |
A study of certain substituted sulphonohydrazides for carcinogenicity in mice.
Topics: Animals; Female; Hydrazines; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasms, Experimental; Sulfonic Acids | 1971 |
[Results of radiologic and cytostatic combination therapy in malignant diseases].
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lung Neoplasms; Male; Neoplasms | 1967 |
Induction of tumors in rats with procarbazine hydrochloride.
Topics: Amides; Animals; Carcinoma, Squamous Cell; Female; Hemangioendothelioma; Hydrazines; Hydrochloric Acid; Intestinal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Rats; Splenic Neoplasms; Uterine Neoplasms | 1968 |
[Polychemotherapy of bronchopulmonary cancers (apropos of 21 cases)].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Azirines; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Synergism; Humans; Hydrazines; Injections, Intramuscular; Injections, Intravenous; Lung Neoplasms; Mechlorethamine; Mercaptopurine; Methotrexate; Middle Aged; Vinblastine | 1968 |
[The results of attack polychemotherapy in broncho-pleuro-pulmonary cancer. Phytohemagglutinin in the prevention and treatment of hematologic complications of antimitotics].
Topics: Anemia, Aplastic; Antibiotics, Antineoplastic; Antineoplastic Agents; Azirines; Bronchial Neoplasms; Drug Synergism; Fluorouracil; Humans; Hydrazines; Injections, Intramuscular; Injections, Intravenous; Lectins; Lung Neoplasms; Mechlorethamine; Mercaptopurine; Methotrexate; Pleural Neoplasms; Vinblastine | 1968 |
[Trial polychemotherapy of inoperable cancer (apropos of 71 cases)].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Azirines; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Synergism; Fluorouracil; Humans; Hydrazines; Injections, Intravenous; Lung Neoplasms; Mechlorethamine; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Pleural Neoplasms; Vinblastine | 1968 |
[Clinical trial of polychemotherapy of inoperable bronchopulmonary cancers].
Topics: Antineoplastic Agents; Azirines; Bronchial Neoplasms; Cyclophosphamide; Drug Synergism; Fluorouracil; Humans; Hydrazines; Injections, Intramuscular; Injections, Intravenous; Lung Neoplasms; Mercaptopurine; Methotrexate; Vinblastine | 1968 |
[Results of a trial of a methylhydrazine in the treatment of epidermoid and anaplastic cancers of the lung].
Topics: Carcinoma, Squamous Cell; Hydrazines; Lung Neoplasms; Methylation | 1968 |
[Modalities and results of anticancer polychemotherapy in 73 cases of advanced broncho-pleuro-pulmonary cancer].
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Drug Synergism; Female; Fluorouracil; Humans; Hydrazines; Injections, Intramuscular; Injections, Intravenous; Lung Neoplasms; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Middle Aged; Vinblastine | 1968 |
[Polychemotherapy of bronchopulmonary cancer].
Topics: Antineoplastic Agents; Azirines; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Synergism; Fluorouracil; Humans; Hydrazines; Lung Neoplasms; Mercaptopurine; Mesothelioma; Methotrexate; Neoplasm Metastasis; Vinblastine | 1968 |
Hepatic carcinogenesis in CBA-Cb-Se mice and Cb-Se rats by isonicotinic acid hydrazide and hydrazine sulfate.
Topics: Adenofibroma; Animals; Female; Genetics; Hydrazines; Isoniazid; Liver; Liver Neoplasms; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Rats; Sarcoma, Experimental; Species Specificity | 1968 |
[218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Drug Synergism; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Hydrazines; Injections, Intramuscular; Injections, Intravenous; Lectins; Lung Neoplasms; Mechlorethamine; Mercaptopurine; Methotrexate; Mouth Neoplasms; Neoplasm Metastasis; Pharyngeal Neoplasms; Urogenital Neoplasms; Vinblastine | 1968 |
[Ultrastructure of pulmonary tumors induced with hydrazine sulfate in BALB-c-Cb-Se mice].
Topics: Adenoma; Animals; Cystadenoma; Hydrazines; Lung Neoplasms; Mice; Neoplasms, Experimental | 1968 |
[Pulmonary tumorigenesis with or without infarcts caused by fluorocarbon, isoniazid or hydrazine sulfate in Osborne-Mendel-Se rats].
Topics: Animals; Fluorocarbon Polymers; Hydrazines; Isoniazid; Lung Neoplasms; Neoplasms, Experimental; Pulmonary Embolism; Rats | 1968 |
Comparative carcinogenicity of N-isopropyl-alpha-(2-methylhydraziono)-p-toluamide. HCI (procarbazine hydrochloride), its degradation products, other hydrazines, and isonicotinic acid hydrazide.
Topics: Amides; Animals; Azo Compounds; Carcinogens; Cystadenoma; Hydrazines; Isoniazid; Kidney Neoplasms; Leukemia; Lung Neoplasms; Male; Mice; Neoplasms, Experimental | 1969 |
Lung tumor induction and inhibition of breast adenocarcinomas by hydrazine sulfate in mice.
Topics: Adenocarcinoma; Animals; Body Weight; Carcinoma; Depression, Chemical; Female; Hydrazines; Isoniazid; Lung Neoplasms; Lymphoma; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Sex Factors; Stimulation, Chemical; Sulfates | 1969 |
Comparative study of lung carcinogenesis, promoting action in leukaemogenesis and initiating action in skin tumorigenesis by urethane, hydrazine and related compounds.
Topics: Animals; Carcinogens; Hydrazines; Leukemia, Experimental; Lung Neoplasms; Mice; Skin Neoplasms; Urethane | 1969 |
[Clinical experiences with the cytostatic drug natulan].
Topics: Adenocarcinoma; Adult; Aged; Amides; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lung Neoplasms; Lymphoma, Non-Hodgkin; Macrophages; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Radiography | 1969 |
[Pulmonary tumors due to hydrazine sulfate administered to newborn mice of te BALB-c/Cb/Se substrain].
Topics: Animals; Animals, Newborn; Carcinogens; Hydrazines; Lung Neoplasms; Mice; Neoplasms, Experimental | 1965 |
[Tumors of the lung induced with hydrazine hydrate in mice of the BALB-c-Cb-Se substrain].
Topics: Animals; Hydrazines; Lung Neoplasms; Mice; Neoplasms, Experimental | 1965 |
Late findings in pulmonary carcinogenesis by hydrazine sulphate in newborn BALB-c-Cb-Se substrain mice.
Topics: Animals; Animals, Newborn; Hydrazines; Lung Neoplasms; Mice; Neoplasms, Experimental | 1965 |
Pulmonary tumours in rats induced by oral hydrazine sulphate.
Topics: Adenocarcinoma, Papillary; Adenoma; Animals; Carcinogens; Carcinoma, Squamous Cell; Female; Hydrazines; Lung Neoplasms; Male; Rats | 1966 |